ChemotherapyFDA-approvedSecond-line

Cladribine

How it works

Interferes with DNA synthesis, preventing cancer cell growth and division.

Cancer types

Leukemia— All patients

Efficacy

Clinical trials have shown that cladribine can induce complete remission in around 20% of patients, with a median overall survival of approximately 8 months.

Side effects

Severe

This treatment carries a higher risk of serious side effects. Close medical monitoring is required throughout treatment.

Evidence from research

Study	Cancer type	Stage	Efficacy
Comparing Oral and IV Cladribine for Leukemia Treatment	Leukemia	phase-1	—	Source →

This information is provided for general education only and is not medical advice. Always consult a qualified healthcare professional before making treatment decisions.